Clinical Pharmacology and Therapeutics: drug-drug interactions (June 2019)

  • Clin Pharmacol Ther. 2019;105:1272-1278. Come dance with me: Transformative changes in the science and practice of drug-drug interactions. Venkatakrishnan K, Rostami-Hodjegan A. PubMed
  • Clin Pharmacol Ther. 2019;105:1289-1291. Drug-drug interactions: Progress over the past decade and looking ahead to the future. Derendorf H, von Richter O, Hermann R, Rostami-Hodjegan A. PubMed
  • Clin Pharmacol Ther. 2019;105:1295-1299. Clopidogrel as a perpetrator of drug-drug interactions: a challenge for quantitative predictions? Varma MVS, Bi YA, Lazzaro S, West M. PubMed
  • Clin Pharmacol Ther. 2019;105:1345-1361. Clinical studies on drug-drug interactions involving metabolism and transport: methodology, pitfalls, and interpretation. Tornio A, Filppula AM, Niemi M, Backman JT. PubMed
  • Clin Pharmacol Ther. 2019;105:1395-1406. Pharmacodynamic drug-drug interactions. Niu J, Straubinger RM, Mager DE. PubMed
  • Clin Pharmacol Ther. 2019;105:1329-1331. The impact of formulation, delivery, and dosing regimen on the risk of drug-drug interactions. Darwich AS, von Moltke L. PubMed
  • Clin Pharmacol Ther. 2019;105:1326-1328. Practical assessment of clinical drug-drug interactions in drug development using physiologically based pharmacokinetics modeling. Shebley M, Einolf HJ. PubMed
  • Clin Pharmacol Ther. 2019;105:1286-1288. Past, present, and future of drug-drug interactions. Levy RH, Ragueneau-Majlessi I. PubMed
  • Clin Pharmacol Ther. 2019;105:1362-1377. Contemporary drug-drug Interactions in HIV treatment. Devanathan AS, Anderson DJC, Cottrell ML, Burgunder EM, Saunders AC, Kashuba ADM. PubMed
  • Clin Pharmacol Ther. 2019;105:1386-1394. Clinical aspects of transporter-mediated drug-drug interactions. Gessner A, König J, Fromm MF. PubMed
  • Clin Pharmacol Ther. 2019;105:1332-1334. Considerations for biologic product drug-drug interactions: a regulatory perspective. Schrieber SJ, Pfuma-Fletcher E, Wang X, Wang YC, Sagoo S, Madabushi R, Huang SM, Zineh I. PubMed
  • Clin Pharmacol Ther. 2019;105:1335-1337. Probes and cocktails for drug-drug interaction evaluation: the future is microdosing? Mikus G. PubMed
  • Clin Pharmacol Ther. 2019;105:1407-1420. From endogenous compounds as biomarkers to plasma-derived nanovesicles as liquid biopsy; Has the golden age of translational pharmacokinetics-absorption, distribution, metabolism, excretion-drug-drug interaction science finally arrived? Rodrigues D, Rowland A. PubMed
  • Clin Pharmacol Ther. 2019;105:1492-1500.  Efficacy and safety exposure-response analyses of Olaparib capsule and tablet formulations in oncology patients. Zhou D, Li J, Learoyd M, Bui K, Berges A, Milenkova T, Al-Huniti N, Tomkinson H, Xu H. PubMed
  • Clin Pharmacol Ther. 2019;105:1501-1512. Impact of genetic variation on Pravastatin systemic exposure in pediatric hypercholesterolemia. Wagner JB, Abdel-Rahman S, Gaedigk R, Gaedigk A, Raghuveer G, Staggs VS, Kauffman R, Van Haandel L, Leeder JS. PubMed